Nevro Reports First Quarter 2023 Financial Results, Provides

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

Related Keywords

California , United States , Costa Rica , Redwood City , Kevin Thornal , D Keith Grossman , Instagram , Linkedin , Exchange Commission , Nevro Corp , Twitter , Facebook , Business Highlights , Constant Currency Compared , First Quarter , Diabetic Neuropathy , Indication Sales , Procedures Increased , Procedures Represented , Thornal Appointed Nevro , New Chief Executive Officer , Grossman Appointed Executive , Full Launch , Spinal Cord Stimulation System , First Powered , Second Quarter , Reiterates Full Year , Constant Currency Growth Over , Full Year Guidance Includes , Growth Over , Executive Chairman , Rod Macleod , Chief Financial , Conference Call Information , Senza Omnia , Looking Statements , Private Securities Litigation Reform Act , Annual Report , Consolidated Statements , Comprehensive Loss , Accepted Accounting Principles , Blow Case , High Case ,